The AD Tx Revolution at ACAAI
Andrew F. Alexis, MD, MPH “We can all appreciate that there has truly been a revolution in our treatment of atopic dermatitis [AD] over the past decade with the emergence of targeted therapies,” Andrew F. Alexis, MD, MPH, asked attendees at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting in … Read more